News
Decision was made Friday after the nonprofit Novo Nordisk Foundation pressed for change The runaway success of GLP-1 drugs made Novo Nordisk, a Danish drugmaker, the top company in Europe by ...
The Novo Nordisk Foundation has committed approximately DKK 600 million ($87.5m) towards the initial costs of the center. The Export and Investment Fund of Denmark has contributed DKK 100m ($14.6m).
The Danish government and the foundation behind Novo Nordisk A/S will invest €80 million ($93 million) in a Microsoft-powered ...
The foundation recently urged Novo Nordisk's leadership to consider an "accelerated CEO succession" and pushed for greater board representation, according to a statement on Friday.
To address this, EIFO and the Novo Nordisk Foundation are investing €80 million to establish QuNorth, a new Nordic quantum initiative. QuNorth's primary mission is to acquire and operate the world's ...
Investing.com -- Denmark’s export and investment fund EIFO and the Novo Nordisk (NYSE: NVO) Foundation are investing €80 ...
The Novo Nordisk Foundation has committed funding for the awards through 2027 and plays no role in the selection of recipients. “The work of Drs. Finkelstein and Agbaje exemplifies the ...
COPENHAGEN/LONDON (Reuters) -Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press conference in Copenhagen: "You ain't seen nothing ...
(Reuters) -The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to expand its tie-up with the United Nations agency for another ...
The foundation behind Novo Nordisk A/S (NVO) and the Danish government will invest €80 million ($93 million) in a Microsoft ...
Novo Nordisk’s main shareholder — the Novo Nordisk Foundation — initiated the move. The century-old nonprofit foundation has 75% of the voting rights and holds just under a third of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results